Canary Foundation
 | The topic of this article may not meet Wikipedia's notability guidelines for companies and organizations. (June 2019) |
The Canary Foundation is a non-profit organization dedicated to discovering highly sensitive and specific biomarkers of early stage cancer and building tests for these markers.[1] The research goal is to be able to identify cancer through a simple blood test, soon after its development, so that treatment has a higher chance of success.
Partnerships
[edit]It was founded in 2004 by former Cisco Systems executive vice president Don Listwin.[1] As of 2006[update], the Science Team included the Nobel Laureate Lee Hartwell, and had partnerships with multiple cancer research centers, including the Fred Hutchinson Cancer Research Center, Stanford University Medical Center, BC Cancer Agency, and University of California, San Francisco Helen Diller Family Comprehensive Cancer Center.
In June 2009, the Canary Foundation, together with Stanford University, committed $20 million to the creation of a research center dedicated to improving cancer early detection.[2]
References
[edit]- ^ a b Printz, Carrie (2010). "New foundation focused on the early detection of cancer". Cancer. 116 (4): 777–778. doi:10.1002/cncr.24977. ISSN 1097-0142. PMID 20127980.
- ^ "Canary Foundation and Stanford University Commit $20 Million for World-Class Research Center for Cancer Early Detection". NonProfit PRO. Retrieved 2020-01-29.
External links
[edit]
 | This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
 | This oncology article is a stub. You can help Wikipedia by expanding it. |